FDA daily

FDA daily for Tuesday, November 10, 2026

In this issue: 26 shortage updates, 18 approvals, 26 device recalls, 31 device decisions and 226 label changes. 3 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug shortages

FDA date:

FDA updated 26 shortage entries on Mon, Nov 9: 26 status updates.

Browse drug shortages in FDA data →

Drug and biologic approvals

FDA date:

On Tue, Nov 3 FDA approved 4 new applications (0 brand or biologic, 4 generic) and 14 supplements to existing ones.

  • OLOPATADINE HYDROCHLORIDE

    ALEMBIC · OLOPATADINE HYDROCHLORIDE

    ANDA217856Generic (ANDA)Over-the-counter
  • FLUTICASONE PROPIONATE

    TEVA PHARMS USA INC · FLUTICASONE PROPIONATE

    ANDA209917Generic (ANDA)Prescription
  • HYDROXYUREA

    ESJAY PHARMA · HYDROXYUREA

    ANDA220300Generic (ANDA)Prescription
  • PROPOFOL

    BAXTER HLTHCARE CORP · PROPOFOL

    ANDA203421Generic (ANDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 26 device recalls from 8 firms on Tue, Nov 3.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 14 510(k)s and 17 PMA decisions on Tue, Oct 27, including 1 original PMA.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

226 drug labels took effect on Tue, Oct 27; 2 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

  • Note Mattifying Extreme Wear Foundation

    OCTINOXATE · ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI · TOPICAL

    Sunscreen & SPFHUMAN OTC DRUG
  • Tretinoin

    TRETINOIN · A-S Medication Solutions · TOPICAL

    Prescription topicalsHUMAN PRESCRIPTION DRUG
  • Carmustine

    CARMUSTINE · Navinta LLC

    Boxed warningHUMAN PRESCRIPTION DRUG
  • XELSTRYM

    DEXTROAMPHETAMINE · Noven Therapeutics, LLC · TRANSDERMAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Clonazepam

    CLONAZEPAM · PD-Rx Pharmaceuticals, Inc. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • sirolimus

    SIROLIMUS · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • carmustine

    CARMUSTINE · Zydus Pharmaceuticals USA Inc.

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Methotrexate

    METHOTREXATE · Hospira, Inc. · INTRAMUSCULAR, INTRAVENOUS +2

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Levothyroxine sodium

    LEVOTHYROXINE SODIUM · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
Browse label updates in FDA data →

FDA did not answer for Drug recalls, Food and supplement recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.